Testing immune markers to predict outcomes in ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with suspected or confirmed ovarian cancer that may be primary or has come back
- Your doctor plans surgery and/or chemotherapy and/or immunotherapy for your cancer
- You can take part in treatment and follow-up visits and can share the needed information with the study team
- Your overall health is good enough for daily activities (performance status 0–2)
- You can sign informed consent (and any medical/mental situation would allow meaningful consent and study completion)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes in your immune system's T-cells (measured from blood samples) can help predict if ovarian cancer comes back. If you are newly diagnosed with advanced ovarian cancer and planning standard treatments (surgery plus chemo), you may join.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This study examines how to improve the immune system's response during ovarian cancer surgery, potentially helping the body fight the cancer better. It compares patients with ovarian cancer to women having surgery for non-cancerous conditions.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.